PharmiWeb.com - Global Pharma News & Resources
02-Apr-2025

BioPure advances manufacturing of BioClamp® to bring significant sustainability benefits to its users

  • BioPure, a leading provider of single-use fluid path components and connectors since 1998, has advanced the manufacturing of BioClamp to bring sustainability benefits to users
  • BioClamp is manufactured to be 13% lighter than the previous model, with a 26% reduction in carbon dioxide emissions across the full lifecycle of the product
  • Competitive bulk order prices are available due to highly efficient manufacturing methods

Devens, MA, USA, 1st April 2025 / Sciad Communications / BioPure, a leading provider of single-use solutions and part of Watson-Marlow Fluid Technology Solutions (WMFTS), has refined the manufacturing of its single-use sanitary BioClamp® to produce sustainability benefits for users.

BioPure, the creators of the first single-use sanitary bioclamp for the bioprocessing market in 1998, has optimised BioClamp in both its design and manufacturing process.

A 13% reduction in weight compared to the previous BioClamp model and the adoption of advanced automated assembly has resulted in 26% less carbon dioxide emissions during manufacturing across the full lifecycle of the product.

Competitive bulk order prices are available due to the highly efficient manufacturing methods of BioClamp, which securely attaches sanitary fittings and is ideal for single-use critical fluid transfer lines.

Additionally, an advanced ergonomic hinge makes BioClamp easier to close and simplifies the set-up of an assembly process, with quick changeovers.

Mark Lovallo, Product Manager for WMFTS, said: “From enhanced production to shipment, use in a bioprocess and end-of-life disposal, BioClamp is designed for sustainability while maintaining the highest quality standards.

“BioClamp is efficiently manufactured, pre-assembled and packaged at our global network of state-of-the-art Class 7 cleanrooms which gives users of our sanitary bioclamp confidence in quality and sustainability as they scale up their production. These facilities are ISO14001 certified and powered by renewable energy.”

Features and benefits

  • Lighter weight and optimised manufacturing reduce carbon emissions across the lifecycle of the product
  • Closure mechanism simplifies the set-up of your assembly process
  • Made from USP Class VI glass-reinforced Nylon
  • Reduced distortion on polymeric fittings when subjected to heat
  • Suitable for sterilisation by autoclave and gamma irradiation
  • Tamper evident feature available
  • Suitable for single-use or multiple-use applications
  • Global manufacturing and supply network for reliable availability

WMFTS is committed to reaching net-zero for its scope 1 and 2 emissions (emissions that are in its direct control), and reducing scope 3 emissions (those the company is indirectly responsible for, up and down its value chain), by 2030. The optimised BioClamp is a testament to this commitment.

ENDS

For further information, please contact:

Lauren Gill, PR Manager
Watson-Marlow Fluid Technology Solutions
E: lauren.gill@wmfts.com

​Sciad Communications, Media Relations

Juliette Craggs / Jasmin Shearan
E: watsonmarlow@sciad.com
T: +44 (0)20 3405 7892

Notes to editors

About Watson-Marlow Fluid Technology Solutions

Watson-Marlow Fluid Technology Solutions (WMFTS) is a world leader in manufacturing peristaltic pumps and associated fluid path technologies for the life sciences and process industries. WMFTS is part of Spirax Group (Spirax-Sarco Engineering plc), with operations in 42 countries. Further information can be found at www.wmfts.com

Editor Details

Related Links

Last Updated: 02-Apr-2025